| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Radiology (Drs. Muzik, D.C. Chugani, and H.T. Chugani), Neurology (Drs. da Silva, Shah, Watson, and H.T. Chugani), Pediatrics (Drs. Juhasz, D.C. Chugani, Nagy, and H.T. Chugani), and Neurosurgery (Dr. Canady), Children’s Hospital of Michigan and the Detroit Medical Center, Wayne State University School of Medicine, Detroit, MI; the Max-Planck-Institute for Neurological Research (Drs. von Stockhausen and Herholz), Cologne, Germany; and The Minnesota Epilepsy Group (Drs. Gates, Frost, and Ritter), St. Paul, MI.
Address correspondence and reprint requests to Dr. Harry T. Chugani, Children’s Hospital of Michigan, Pediatric Neurology/PET Center, 3901 Beaubien Blvd., Detroit, MI 48201; e-mail: hchugani{at}pet.wayne.edu
OBJECTIVE: To compare abnormalities determined in 2-deoxy-2-[18F]fluoro-D-glucose (FDG) and [11C]flumazenil (FMZ) PET images with intracranial EEG data in patients with extratemporal lobe epilepsy.
BACKGROUND: Although PET studies with FDG and FMZ are being used clinically to localize epileptogenic regions in patients with refractory epilepsy, the electrophysiologic significance of the identified PET abnormalities remains poorly understood.
METHODS: We studied 10 patients, mostly children (4 boys, 6 girls, aged 2 to 19 years; mean age, 11 years), who underwent FDG and FMZ PET scans, intracranial EEG monitoring, and cortical resection for intractable epilepsy. EEG electrode positions relative to the brain surface were determined from MRI image volumes. Cortical areas of abnormal glucose metabolism or FMZ binding were determined objectively based on asymmetry measures derived from homotopic cortical areas at three asymmetry thresholds. PET data were then coregistered with the MRI and overlaid on the MRI surface. A receiver operating characteristics (ROC) analysis was performed to determine the specificity and sensitivity of PET-defined abnormalities against the gold standard of intracranial EEG data.
RESULTS: FMZ PET detected at least part of the seizure onset zone in all subjects, whereas FDG PET failed to detect the seizure onset region in two of 10 patients. The area under the ROC curves was higher for FMZ than FDG PET for both seizure onset (p = 0.01) and frequent interictal spiking (p = 0.04). Both FMZ and FDG PET showed poor performance for detection of rapid seizure spread (area under the ROC curve not significantly different from 0.5).
CONCLUSIONS: [11C]flumazenil (FMZ) PET is significantly more sensitive than 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET for the detection of cortical regions of seizure onset and frequent spiking in patients with extratemporal lobe epilepsy, whereas both FDG and FMZ PET show low sensitivity in the detection of cortical areas of rapid seizure spread. The application of PET, in particular FMZ PET, in guiding subdural electrode placement in refractory extratemporal lobe epilepsy will enhance coverage of the epileptogenic zone.
Key words: Flumazenil—Glucose metabolism—PET—Extratemporal epilepsy—Epilepsy surgery
This article has been cited by other articles:
|
|
 |
|
  K.K. Lee and N. Salamon [18F] Fluorodeoxyglucose-Positron-Emission Tomography and MR Imaging Coregistration for Presurgical Evaluation of Medically Refractory Epilepsy AJNR Am. J. Neuroradiol., November 1, 2009; 30(10): 1811 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Juhasz, E.M. Haacke, J. Hu, Y. Xuan, M. Makki, M.E. Behen, M. Maqbool, O. Muzik, D.C. Chugani, and H.T. Chugani Multimodality Imaging of Cortical and White Matter Abnormalities in Sturge-Weber Syndrome AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 900 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Benedek, C. Juhasz, D. C. Chugani, O. Muzik, and H. T. Chugani Longitudinal Changes in Cortical Glucose Hypometabolism in Children With Intractable Epilepsy J Child Neurol, January 1, 2006; 21(1): 26 - 31. [Abstract] [PDF]
|
|
|
|
|
|
A. F. Luat, E. Asano, C. Juhasz, S. R. Chandana, A. Shah, S. Sood, and H. T. Chugani Relationship Between Brain Glucose Metabolism Positron Emission Tomography (PET) and Electroencephalography (EEG) in Children With Continuous Spike-and-Wave Activity During Slow-Wave Sleep J Child Neurol, August 1, 2005; 20(8): 682 - 690. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Hammers, M. J. Koepp, M. P. Richardson, R. Hurlemann, D. J. Brooks, and J. S. Duncan Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients Brain, June 1, 2003; 126(6): 1300 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Juhasz, D.C. Chugani, O. Muzik, A. Shah, E. Asano, T.J. Mangner, P.K. Chakraborty, S. Sood, and H.T. Chugani Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy Neurology, March 25, 2003; 60(6): 960 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Pfund, K. Kagawa, C. Juhasz, Chenggang Shen, Joon Soo Lee, D. C. Chugani, O. Muzik, and H. T. Chugani Quantitative Analysis of Gray- and White-Matter Volumes and Glucose Metabolism in Sturge-Weber Syndrome J Child Neurol, February 1, 2003; 18(2): 119 - 126. [Abstract] [PDF]
|
|
|
|
|
|
A. Hammers, M. J. Koepp, R. Hurlemann, M. Thom, M. P. Richardson, D. J. Brooks, and J. S. Duncan Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI Brain, October 1, 2002; 125(10): 2257 - 2271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hammers, M. J. Koepp, M. P. Richardson, C. Labbe, D. J. Brooks, V. J. Cunningham, and J. S. Duncan Central benzodiazepine receptors in malformations of cortical development: A quantitative study Brain, August 1, 2001; 124(8): 1555 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Lee, E. Asano, O. Muzik, D. C. Chugani, C. Juhasz, Z. Pfund, S. Philip, M. Behen, and H. T. Chugani Sturge-Weber syndrome: Correlation between clinical course and FDG PET findings Neurology, July 24, 2001; 57(2): 189 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Juhasz, D. C. Chugani, O. Muzik, A. Shah, J. Shah, C. Watson, A. Canady, and H. T. Chugani Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome Neurology, June 26, 2001; 56(12): 1650 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Juhasz, D. C. Chugani, O. Muzik, C. Watson, J. Shah, A. Shah, and H. T. Chugani Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy Neurology, September 26, 2000; 55(6): 825 - 835. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
